Cargando…

Recent advances in the management of pulmonary hypertension with interstitial lung disease

Pulmonary hypertension (PH) is known to complicate various forms of interstitial lung disease (ILD), including idiopathic pulmonary fibrosis, the interstitial pneumonias and chronic hypersensitivity pneumonitis. Pathogenesis of PH-ILD remains incompletely understood, and probably has overlap with ot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waxman, Aaron B., Elia, Davide, Adir, Yochai, Humbert, Marc, Harari, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724812/ https://www.ncbi.nlm.nih.gov/pubmed/35831007 http://dx.doi.org/10.1183/16000617.0220-2021

Ejemplares similares

Pulmonary hypertension in patients with chronic myeloproliferative disorders
por: Adir, Yochai, et al.
Publicado: (2015)

Rare pulmonary disease and orphan drugs: a path to the future
por: Harari, Sergio, et al.
Publicado: (2019)

Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
por: Harari, Sergio, et al.
Publicado: (2021)

COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
por: Adir, Yochai, et al.
Publicado: (2021)

Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021)

Recent advances in managing idiopathic pulmonary fibrosis
por: Scelfo, Chiara, et al.
Publicado: (2017)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

Pulmonary hypertension and chronic lung disease: where are we headed?
por: Elia, Davide, et al.
Publicado: (2019)

Asthma and COVID-19: an update
por: Adir, Yochai, et al.
Publicado: (2021)

Rare pulmonary diseases: a common fight
por: Harari, Sergio, et al.
Publicado: (2017)

Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT
por: Foris, Vasile, et al.
Publicado: (2019)

Cellular interactions in the pathogenesis of interstitial lung diseases
por: Bagnato, Gianluca, et al.
Publicado: (2015)

Lung injury related to extreme environments
por: Adir, Yochai, et al.
Publicado: (2014)

Recent Advances in the Treatment of Interstitial Lung Diseases
por: Bang, Aneesh A, et al.
Publicado: (2023)

Recent advances in the management of pulmonary arterial hypertension
por: Tsai, Halley, et al.
Publicado: (2016)

Pulmonary hypertension: a paradigm for rare pulmonary diseases
por: Harari, Sergio
Publicado: (2017)

Depression in Pulmonary Arterial Hypertension and Interstitial Lung Diseases
por: Verma, Sameer, et al.
Publicado: (2014)

Noninvasive determinants of pulmonary hypertension in interstitial lung disease
por: Joseph, Phillip, et al.
Publicado: (2023)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
por: Waxman, Aaron, et al.
Publicado: (2023)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Pulmonary Hypertension in Interstitial Lung Disease: Management Options to Move Beyond Supportive Care
por: Fabyan, Kimberly D., et al.
Publicado: (2023)

The European Respiratory Review: continuing the success and targeting new challenges
por: Adir, Yochai
Publicado: (2019)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

The role of combination therapy in managing pulmonary arterial hypertension
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2014)

Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases
por: Exarchos, Konstantinos P., et al.
Publicado: (2023)

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
por: Haynes, Zachary A., et al.
Publicado: (2023)

Recent advances in pulmonary arterial hypertension
por: Wilkins, Martin R., et al.
Publicado: (2018)

Ultra-rare disease: an European perspective
por: Harari, Sergio, et al.
Publicado: (2020)

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
por: Kamenova, Antoniya, et al.
Publicado: (2023)

Predictors of mortality in interstitial lung disease patients without pulmonary hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
por: Dhont, Sebastiaan, et al.
Publicado: (2022)

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
por: Torre, Olga, et al.
Publicado: (2017)

Recent advances in the management of hypertension
por: García-Donaire, José Antonio, et al.
Publicado: (2010)

A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
por: Waxman, Aaron B
Publicado: (2007)

Pulmonary hypertension in chronic lung disease and hypoxia
por: Nathan, Steven D., et al.
Publicado: (2019)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
por: Otani, Naoyuki, et al.
Publicado: (2022)

Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1
por: Rodrigues, Daniela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5e5c7p87ucfp0df0mir37utqj4